A roundup of recent stock market activity, including changes in short interest, earnings expectations, analyst ratings, and institutional investor holdings for several companies. Read more...

Several investment firms, including Illinois Municipal Retirement Fund, New York Life, and Oppenheimer, have adjusted their holdings in companies like NV5 Global, Zillow, and Jazz Pharmaceuticals. Nebius expresses confidence in its AI potential. Read more...

A summary of recent analyst ratings for several companies, including AMN Healthcare, MindMed, Public Storage, Keurig Dr Pepper, Tectonic Therapeutic, and TWFG, Inc. Read more...

A look at the latest earnings estimates and analyst outlook for several companies including Alphabet, Rocket Pharmaceuticals, Pharming Group, Structure Therapeutics, uCloudlink Group, and Longeveron. Read more...

This article summarizes recent market activity, including Whipplewood Advisors' investment in Meta, analyst rating changes for Mattel and Noodles & Company, and Wedbush's updated earnings estimates for Apellis Pharmaceuticals. Read more...

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB. Read more...

Recent market volatility has created potential buying opportunities. This article explores the dip in tech stocks, focusing on AI leaders like Nvidia and other promising companies like Palantir and Devon Energy. Read more...

A roundup of recent analyst ratings and price target adjustments for companies like NetApp, Lexicon Pharmaceuticals, Medpace Holdings, and more. Plus, a look at Nvidia vs. Broadcom in the AI space. Read more...

A look at the potential impact of US tariffs on the Czech Republic, Germany's renewed ambition, and pharmaceutical companies suing the EU over wastewater treatment costs. Read more...

A look at the latest business news, including Rigel Pharmaceuticals' earnings call, Unifi's cost-cutting plans, Analog Devices' buy rating, and Visa/Mastercard investment opportunities. Read more...

This week in health: Fatty liver disease linked to cancer risk in Malaysia, a mechanic customizes wheelchairs, sleep deprivation's impact on immunity, and a court ruling on Ivermectin. Read more...

A look at recent stock movements in the tech and medical sectors, highlighting insider buying in Sunrun, a price target reduction for GigaCloud, and disappointing earnings from Syndax. Read more...

Asian shares show mixed performance amid Trump's tariffs, while some US companies see stock fluctuations after earnings reports. Direct mail marketing also remains relevant. Read more...

Volvo challenges SUV dominance with the ES90, while Pfizer faces a patent infringement ruling in Germany. Also, Germany plans a large spending increase and DHL cuts jobs. Read more...

A summary of recent analyst ratings for several publicly traded companies, including Advanced Energy Industries, Atlassian, Boot Barn, Sage Therapeutics, Janus Henderson, and The RealReal. Read more...

A quick roundup of the latest business news, covering Vertex Pharmaceuticals' strong rating, Fortuna Mining's Q4 call, housing unaffordability, and Hewlett Packard Enterprise's Q1 results. Read more...

A look at the new market volatility regime, Apple's upcoming iPhone 16e and its stock implications, plus key takeaways from recent earnings calls for Atea Pharmaceuticals and Methode Electronics. Read more...

A roundup of recent earnings call transcripts and an analysis of Mayville Engineering's investment potential, offering insights into company performance and future outlook. Read more...

Recent reports highlight key developments for Tesla, Sweetgreen, and Solana, including analyst concerns, earnings reports, and investment opportunities. Read more...

A roundup of recent analyst ratings for various stocks, including Astronics, Lloyds Banking Group, Oklo, Amylyx Pharmaceuticals, NatWest Group, and GE Vernova, providing insights for investors. Read more...